Key Highlights
- CureMint names John Klavon as Vice President of Sales and Business Development.
- Klavon brings over 32 years of dental and B2B sector experience.
- Led procurement at Frontline Dental, achieving $2.8 million in savings using CureMint’s platform.
- Expertise in unifying Procurement and A/P workflows to drive efficiency and growth.
Source: Business Wire
Notable Quotes
- “John recognized that today’s modern dental organizations need more than a procurement solution. They need an integrated Procure-to-Pay solution.” — Tyson Nargassans, CEO at CureMint
- “I’m excited to join CureMint and look forward to leveraging my experience in the dental industry to contribute to CureMint’s vision and long-term success.” — John Klavon, VP of Sales and Business Development at CureMint
SoHC's Take
CureMint’s appointment of John Klavon marks a pivotal moment for the company, aligning with its mission to continue expanding its foothold in the dental sector. Klavon’s extensive leadership experience and firsthand success with CureMint’s platform at Frontline Dental suggest he is well-positioned to drive both sales and innovation. His deep understanding of dental organizations’ unique challenges, combined with his strategic mindset, will undoubtedly help CureMint further solidify its position as a leader in Procure-to-Pay solutions.
Heading
Key Highlights Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.Collaboration with Google Cloud enables AI-driven drug discovery tools.Open API allows researchers to access Ginkgo’s machine ...
Key Highlights Courtney Green joins QGenda as Vice President of Nurse and Staff Solutions.Brings over 20 years of clinical and operational leadership experience.Focus on optimizing ...
Key Highlights Vyne Medical® acquires Extract Systems®, a leader in data extraction solutions.Accelerates healthcare automation by integrating AI and machine learning ...
Key Highlights PatientPay integrates with Azalea Health’s API to streamline patient billing for ambulatory providers.Faster revenue capture with less than 14 days to payment, ...
Key Highlights Partnership streamlines revenue cycle management for ABA therapy providers.Flychain’s financial tools offer real-time insights, secure funding, and automation.Raven ...
Key Highlights Nura Bio closes $140M Series A financing to support clinical development.Shilpa Sambashivan, Ph.D., appointed as CEO following Phase 1 success ...
